Interleukin 1 (IL 1)-dependent lymphokine production by human leukemic T cell line HSB.2 subclones.
Open Access
- 1 March 1985
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 134 (3) , 1682-1689
- https://doi.org/10.4049/jimmunol.134.3.1682
Abstract
Cloning of a human T cell leukemic cell line, HSB.2, was performed by a limiting dilution method to obtain clones with high levels of IL 2 production. None of the subclones that were obtained produced IL 2 constitutively, and only a low level of IL 2 was produced by the stimulation of these subclones with phytohemagglutinin (PHA) alone. High levels of IL 2 production (greater than 300 U/ml) were observed in several clones when stimulated with a cocktail of PHA and IL 1. Among them, HSB.2-A7-D2, A7-D9, or C5-B2 subclones, which were selected after cloning twice, were most effective in IL 1-dependent IL 2 production. HSB.2 subclones exhibited IL 1-dependent production of a variety of lymphokines other than IL 2, e.g., interferon-gamma (IFN-gamma), B cell growth factor (BCGF), and colony-stimulating factor (CSF). We observed that subclones with high IL 2-producing capacity tended to produce high levels of IFN-gamma or BCGF as well, while the capacity of CSF production was not parallel to these properties. Although several subclones were found to produce IFN-gamma and BCGF simultaneously with minimal IL 2 activity, no subclones with an exclusive BCGF production were obtained. Furthermore, when supernatants from the stimulated A7-D9 subclone were applied to an Ultro-gel AcA54 gel chromatography, it was revealed that IL 2 activity (m.w. 17K to 18K) and IFN-gamma (40K to 45K) were clearly separated, whereas two peaks of BCGF activity coincided with each peak of IL 2 and IFN-gamma, respectively. On the other hand, CSF activity was eluted at a different peak (30K to 35K). These data indicate that IL 2, IFN-gamma, and CSF activities are based on distinct molecules, whereas BCGF activities are indistinguishable from IL 2 and IFN-gamma. The HSB.2 subclones thus selected will provide a useful model for delineating the mechanism of IL 1-dependent lymphokine(s) production, and are a promising candidate for better lymphokine(s) producers.This publication has 13 references indexed in Scilit:
- Characterization of human B cell growth factor (BCGF) from cloned T cells or mitogen-stimulated T cells.The Journal of Immunology, 1983
- Differential sensitivity of human B cell subsets to activation signals delivered by anti-mu antibody and proliferative signals delivered by a monoclonal B cell growth factor.The Journal of Experimental Medicine, 1983
- Interleukin 1, a potential regulator of fibroblast proliferation.The Journal of Immunology, 1982
- POTENTIATION OF NATURAL-KILLER CELL-ACTIVITY OF HUMAN-LYMPHOCYTES INVITRO - THE PARTICIPATION OF INTERFERON IN STIMULATION WITH STAPHYLOCOCCUS-AUREUS COWAN-I BACTERIA BUT NOT WITH PROTEIN-A1982
- Relationship of cell cycle to recovery of IL 2 activity from human mononuclear cells, human and mouse T cell lines.The Journal of Immunology, 1981
- The role of macrophages in the acute-phase response: SAA inducer is closely related to lymphocyte activating factor and endogenous pyrogenCellular Immunology, 1981
- Stimulation of rheumatoid synovial cell collagenase and prostaglandin production by partially purified lymphocyte-activating factor (interleukin 1).Proceedings of the National Academy of Sciences, 1981
- T-Cell lymphoma model for the analysis of interleukin 1-mediated T-cell activation.Proceedings of the National Academy of Sciences, 1981
- Endogenous pyrogens made by rabbit peritoneal exudate cells are identical with lymphocyte-activating factors made by rabbit alveolar macrophages.The Journal of Immunology, 1980
- MITOGEN REQUIREMENTS FOR THE INVITRO-PROPAGATION OF CUTANEOUS T-CELL LYMPHOMAS1980